Medico Intercontinental Board of Directors
Get the latest insights into the leadership at Medico Intercontinental. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Ms. Tanvi Shah | Chairman & Non-Exe.Director |
| Mr. Samir Shah | Managing Director |
| Ms. Swati Vikramkumar Shah | Non Executive Director |
| Mr. Ankur Dave | Independent Director |
| Mr. Priyank Sancheti | Independent Director |
| Mr. Nikul Shah | Independent Director |
| Mr. Parshwa Shah | Independent Director |
Medico Intercontinental Share price
MIL
36.9
0.03 (-0.08%)Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
39.00
Today's Low
36.31
52 Week Low
32.71
52 Week High
63.59
The current prices are delayed, login to your account for live prices
LoginMedico Intercontinental FAQs
The board at Medico Intercontinental consists of experienced professionals, including Ms. Tanvi Shah , Mr. Samir Shah , and others, overseeing the company’s strategic and corporate governance.
Directors at Medico Intercontinental are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Ms. Tanvi Shah is the current chairman at Medico Intercontinental.
Executive directors at Medico Intercontinental are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Medico Intercontinental adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Medico Intercontinental, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.